Purchase Order 75N93019P00414
- Not listed
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions. The $13,250.00 contract is for a MiSeq Silver Support Plan, with a completion date of September 25, 2020. Illumina has previously received prime federal contracts from agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents, for $105,341.32. The order includes various sequencing products such as the NovaSeq 6000 S2 Reagent Kit, NovaSeq XP 2-Lane Kit, MiSeq Reagent Kit V2, and Nextera XT DNA Library Preparation Kit to support life science research, applied...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The $101,340.96 contract provides a one-year service plan for Illumina's NextSeq and MiSeq sequencing platforms, as well as an iSeq 100 system, to be used at an NIAID facility in Frederick, Maryland. The contract was...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a MiSeq Silver Support Plan. The contract is valued at $15,575.00 and has a completion date of March 25, 2025. Illumina, a for-profit manufacturer of genomic sequencing instruments and reagents, has previously provided sequencing systems and consumables to support research and diagnostics...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $953,700.00 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer, to provide a NOVASEQ 6000 sequencing system. The contract has no set-aside designation and was completed on September 29, 2017. Illumina has previously received prime contracts from various federal agencies, including the NIH, CDC, USDA, and VA, to supply...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic analysis products, to provide TruSeq and MiSeq sequencing kits. The $10,176.95 award supports the agency's research and diagnostics needs, and follows previous prime contract awards to Illumina under which the company has supplied sequencing systems, reagents, and...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the prime contractor Illumina, Inc. for the purchase of MiSeq sequencing kits. The order, valued at $13,071, does not have a set-aside designation. Illumina is a for-profit manufacturer and provider of genetic sequencing and analysis instruments and reagents. The award supports NIAID's genomic research and diagnostics...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the purchase of TruSeq sequencing kits. The order, valued at $8,623.90, does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies like the National Institutes of Health,...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The $3,504.92 award is for the provision of sequencing systems, reagents, and related services to support genomic research and diagnostics. Illumina has a history of providing these types of goods and services to federal...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing systems and analytical instruments. The $7,902 contract is for comprehensive service and support for Illumina's MiSeq gene and small genome sequencer. The award has no set-aside designation and is not associated with a larger contract vehicle. Illumina has been awarded...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,250.00 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis solutions. The 12-month service contract, with a period of performance from April 1, 2019 through March 31, 2020, is for Illumina's MiSeq sequencing system and related services. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Illumina has previously received prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to provide a range of genomic sequencing instruments, reagents, and support services for research and diagnostics purposes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 3/25/19 |